Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Chul S. Ha
P53-Based Strategy for Protection of Bone Marrow From Y-90 Ibritumomab Tiuxetan
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Related publications
CONSOLIDATION THERAPY USING 90 Y-Ibritumomab TIUXETAN AFTER BENDAMUSTINE AND RITUXIMAB FOR RELAPSED FOLLICULAR LYMPHOMA; A MULTICENTER, PHASE II STUDY (BRiZ2012)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
A New Pharmacokinetic Model for 90y-Ibritumomab Tiuxetan Based on 3-Dimensional Dosimetry
Scientific Reports
Multidisciplinary
90 Y-Ibritumomab Tiuxetan in Patients With Extra-Nodal Marginal Zone B-Cell Lymphoma of Mucosa Associated Lymphoid Tissue (Malt Lymphoma) - The Zeno Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Radioimmunotherapy for B-Cell Lymphoma: Y90 Ibritumomab Tiuxetan and I131 Tositumomab
Oncogene
Cancer Research
Genetics
Molecular Biology
MIRD Dose Estimate Report No. 20: Radiation Absorbed-Dose Estimates for 111In- And 90y-Ibritumomab Tiuxetan
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Functional Comparison of Bone Marrow–Derived Liver Stem Cells: Selection Strategy for Cell-Based Therapy
Journal of Gastrointestinal Surgery
Surgery
Gastroenterology
Powerful New Strategy for Allogeneic Bone Marrow Transplantation in Mice
The Journal of Kansai Medical University
Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (With Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Positron Emission Tomography/Computed Tomography Before Treatment as a Predictor of 90y-Ibritumomab Tiuxetan Response
Kitakanto Medical Journal
Medicine
